• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Haemodynamics and serial risk assessment ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1183/13993003.00678-2018
PMID :
30209196
Permalink :
http://hdl.handle.net/20.500.12210/4613
Title :
Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension.
Author(s) :
Weatherald, Jason [Auteur]
Boucly, Athenais [Auteur]
Launay, David [Auteur] refId
Lille Inflammation Research International Center - U 995 [LIRIC]
Cottin, Vincent [Auteur]
Prevot, Gregoire [Auteur]
Bourlier, Delphine [Auteur]
Dauphin, Claire [Auteur]
Chaouat, Ari [Auteur]
Savale, Laurent [Auteur]
Jais, Xavier [Auteur]
Jevnikar, Mitja [Auteur]
Traclet, Julie [Auteur]
De Groote, Pascal [Auteur] refId
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Simonneau, Gerald [Auteur]
Hachulla, Eric [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Mouthon, Luc [Auteur]
Montani, David [Auteur]
Humbert, Marc [Auteur]
Sitbon, Olivier [Auteur]
Journal title :
The European respiratory journal
Abbreviated title :
Eur. Respir. J.
Publication date :
2018-09-12
ISSN :
1399-3003
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk assessment are not well established for systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH).We assessed ...
Show more >
The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk assessment are not well established for systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH).We assessed incident SSc-PAH patients to determine the association between clinical and haemodynamic variables at baseline and first follow-up right heart catheterisation (RHC) with transplant-free survival. RHC variables included cardiac index, stroke volume index (SVI), pulmonary arterial compliance and pulmonary vascular resistance. Risk assessment was performed according to the number of low-risk criteria: functional class I or II, 6-min walking distance (6MWD) >440 m, right atrial pressure <8 mmHg and cardiac index >/=2.5 L.min(-1).m(-2)Transplant-free survival from diagnosis (n=513) was 87%, 55% and 35% at 1, 3 and 5 years, respectively. At baseline, 6MWD was the only independent predictor. A follow-up RHC was available for 353 patients (median interval 4.6 months, interquartile range 3.9-6.4 months). The 6MWD, functional class, cardiac index, SVI, pulmonary arterial compliance and pulmonary vascular resistance were independently associated with transplant-free survival at follow-up, with SVI performing better than other haemodynamic variables. 1-year outcomes were better with increasing number of low-risk criteria at baseline (area under the curve (AUC) 0.63, 95% CI 0.56-0.69) and at first follow-up (AUC 0.71, 95% CI 0.64-0.78).Follow-up haemodynamics and multidimensional risk assessment had greater prognostic significance than at baseline in SSc-PAH.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Institut Pasteur de Lille
Collections :
  • Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement (RID-AGE) - U1167
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Research team(s) :
Immunity, inflammation and fibrsis in auto and allo-reactivity
Submission date :
2019-03-01T14:17:38Z
Université de Lille

Mentions légales
Université de Lille © 2017